| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $317.3M | +5.1% |
| Cost of Revenue | $103.7M | +4.3% |
| Gross Profit | $213.6M | +5.4% |
| R&D Expense | $46.2M | +8.2% |
| SG&A Expense | $70.5M | -8.4% |
| Operating Income | -$40.2M | -16.0% |
| Pre-tax Income | -$70.2M | -5.4% |
| Income Tax | -$1.7M | +79.1% |
| Net Income | -$68.4M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $248.7M | +31.5% |
| Accounts Receivable | $47.6M | -5.8% |
| Current Assets | $321.3M | +22.2% |
| Total Assets | $1.11B | +8.2% |
| Current Liabilities | $151.2M | -3.3% |
| Long-term Debt | $515.0M | -0.6% |
| Total Liabilities | $692.3M | -2.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $30.0M | -28.2% |
| Capital Expenditures | $866K | -22.3% |
| Investing Cash Flow | -$63.2M | +32.4% |
| Financing Cash Flow | $94.2M | +1251.0% |
| Free Cash Flow | $29.1M | -28.3% |
| -17.5% |
| EPS (Basic) | -$2.23 | -16.1% |
| EPS (Diluted) | -$2.23 | -16.1% |
| Stockholders' Equity |
| $308.9M |
| -2.3% |